Article
Study designs in genetic epidemiology.
Methods in molecular biology (Clifton, N.J.) - 1 Jan 2009
Cote Michele L
Abstract excerpt
Identification of germline mutations that may modulate individual risk of developing cancer is a rapidly developing field. Over the last few decades, germline mutations in p53, BRCA1, BRCA2, APC, MLH1, MSH2, and MSH6 have been identified in families with a large number of relatives who have been diagnosed with particular types of cancer. These mutations are rare but substantially increase the risk of cancer in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
